The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

Clinical Tools and Resources for Lung Cancer


The purpose of these clinical tools and resources is to more widely disseminate, in a practical and user-friendly form, the recommendations contained in the guidelines.  In the lung cancer area, ASCO currently has derivative products for a guideline on chemotherapy for stage IV non small cell lung cancer and adjuvant therapy for stages I-IIIa resectable non small cell lung cancer. There are also slides sets for the provisional clinical opinion on EGFR Testing in Non Small Cell Lung Cancer.


Clinical Tools and Resources

Stage IV Non Small Cell Lung Cancer First Line Chemotherapy Decision Aid

Stage IV Non Small Cell Lung Cancer Second Line Chemotherapy Decision Aid

Stage IV Non Small Cell Lung Cancer Second or Third Line Chemotherapy with Erlotinib Decision Aid

Stage IV Non Small Cell Lung Cancer Third or Fourth Line Chemotherapy Decision Aid

Stage IV Non Small Cell Lung Cancer All Decision Aids Set

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer Decision Aid Tool for Stage IB

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer Decision Aid Tool for Stage II

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer Decision Aid Tool for Stage III


Journal of Oncology Practice (JOP) Guideline Articles

2011 Focused Update of the Chemotherapy for Stage IV Non Small Cell Lung Cancer JOP Article

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer JOP Guideline Summary


Summary Slide Set

Chemotherapy for Stage IV Non Small Cell Lung Cancer Slide Set (pps)

Chemotherapy for Stage IV Non Small Cell Lung Cancer Slide Set (pdf)

EGFR Testing in Non Small Cell Lung Cancer Slide Set (pps)

EGFR Testing in Non Small Cell Lung Cancer Slide Set (pdf)

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer Slide Set (ppt)

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer Slide Set (pdf)


Patient Guide

Chemotherapy for Stage IV Non Small Cell Lung Cancer Patient Guide

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer Patient Guide


The practice guideline is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients and may not reflect the most recent evidence. The guideline does not recommend any particular product or course of medical treatment. Use of the practice guideline and summary is voluntary. The full practice guideline and additional information are available at http://www.asco.org/guidelines.


Last Updated: 12/1/11


 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005–2012 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.
Feedback Form